Pfizer officially stated that her tablet for the treatment of coronavirus is effective against the omikron strain. This is stated in the press release of the company dated December 14th.
“Full results of the study with the participation of 2250 people confirmed promising first results: the drug reduced the number of hospitalizations and mortality by 89% among adult patients after the appearance of the first symptoms of COVID-19,” Pfizer says.
The company also stated that, as many experts predicted, individual laboratory tests proved the effectiveness of tablets against the new strain of coronavirus – “Omicron”.
Food and medicine quality management will soon decide on the resolution of PFizer tablets and a competing drug from Merck, which was represented by regulators a few weeks earlier. If both drugs are approved, they will become the first medicines from COVID-19, which can be purchased in pharmacies.